Table 4 Subgroup analysis– impact of frailty on mortality in benign disease and those with malignant diagnoses
Characteristic | Crude HR (95% CI) | p value | Adjusted HR (95% CI) | p value | |
|---|---|---|---|---|---|
Frailty | Not frail (mFI ≤ 0.2) | Reference | |||
Frail (mFI ≥ 0.4) | 4.65 (2.53–8.57) | < 0.0001 | 4.36 (2.17–8.77) | < 0.0001 | |
Malignant diagnosis irrespective of frailty status | 12.04 (7.01–20.68) | < 0.0001 | 10.40 (6.01–18.01) | < 0.0001 | |